Lilly to Acquire Sigilon Therapeutics

INDIANAPOLIS and CAMBRIDGE, Mass., June 29, 2023 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics, Inc. (Nasdaq: SGTX) today announced a definitive agreement for Lilly to acquire Sigilon, a biopharmac... Biopharmaceuticals, Endocrinology, Mergers & Acquisitions Eli Lilly, Sigilon, encapsulated cell therapies
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news